Comparisons of Clinical Features and Outcomes of COVID-19 between Patients with Pediatric Onset Inflammatory

Fatih Haslak1, Sevki Erdem Varol1, Aybuke Gunalp1

  • 1Department of Pediatric Rheumatology, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul 34303, Turkey.

Insights

Children with inflammatory rheumatic diseases (IRD) face higher risks of symptomatic COVID-19 and hospitalization compared to healthy children. Pediatric rheumatologists must closely monitor these patients for potentially worse outcomes.

Area of Science:

  • Pediatric Rheumatology
  • Infectious Diseases
  • Clinical Outcomes

Background:

  • Investigating coronavirus disease-2019 (COVID-19) clinical features and outcomes in pediatric patients with inflammatory rheumatic diseases (IRD).
  • Comparing COVID-19 severity risks in IRD children versus healthy children.

Purpose of the Study:

  • To describe clinical features and outcomes of COVID-19 in children and late adolescents with IRD.
  • To assess the risk of severe COVID-19 in IRD patients compared to healthy controls.

Main Methods:

  • Retrospective study including 658 polymerase chain reaction (PCR)-confirmed SARS-CoV-2 positive subjects (152 IRD patients, 506 healthy children).
  • Inclusion criteria required at least a six-month follow-up duration for IRD patients.

Main Results:

  • Of 658 subjects, 86.6% experienced COVID-19 symptoms; only 3.19% required hospitalization.
  • Inflammatory rheumatic diseases (IRD) significantly increased the risk of hospitalization (OR: 5.205) and symptomatic infection (OR: 2.579).
  • Increasing age was associated with symptomatic infection (OR: 1.051); no deaths or significant sequelae were reported.

Conclusions:

  • Children with IRD have a substantially higher risk of severe COVID-19 outcomes, including hospitalization.
  • Pediatric rheumatologists should maintain close surveillance of IRD patients for COVID-19 management.
  • Early identification and monitoring are crucial for mitigating adverse COVID-19 effects in pediatric rheumatology patients.

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
86
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
35
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
642
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
61
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
45
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
34